Browse > Article

Effects of Lipomyces starkeyi KSM 22 Glucanhydrolase on human gingival fibroblasts  

Yun, Hyun-Jeong (Department of Periodontology, College of Dentistry and Dental Science Research Institute, College of Engineering Chonnam National University)
Chung, Hyun-Ju (Department of Periodontology, College of Dentistry and Dental Science Research Institute, College of Engineering Chonnam National University)
Kim, Ok-Su (Department of Periodontology, College of Dentistry and Dental Science Research Institute, College of Engineering Chonnam National University)
Kim, Do-Man (Department of Biochemical Engineering, College of Engineering Chonnam National University)
Publication Information
Journal of Periodontal and Implant Science / v.32, no.3, 2002 , pp. 665-683 More about this Journal
Abstract
A novel glucanhydrolase from a mutant of Lipomyces starkeyi KSM 22 has additional amylase activity besides mutanolytic activity and has been suggested as promising anti-plaque agent. It has been shown effective in hydrolysis of mutan, reduction of mutan formation by Streptococcus mutans and removal pre-formed sucrose-dependent adherent microbial film and has been strongly bound to hydroxyapatitie. These in vitro properties of Lipomyces starkeyi KSM 22 glucanhydrolase are desirable for its application as a dental plaque control agent. In human experimental gingivitis model and 6 month clinical trial, mouthrinsing with Lipomyces starkeyi KSM 22 dextranase was comparable to 0.12% chlorhexidine mouthwash in inhibition of plaque accumulation and gingival inflammation and local side effect was negligible. This study was aimed to evaluate the cytotoxic effect of Lipomyces starkeyi KSM 22 glucanhydrolase on human gingival fibroblasts. Primary culture of human gingival fibroblasts at the 4th to 6th passages were used. Glucanhydrolase solution was made from lyophilized glucanhydrolase powder from a mutant of Lipomyces stakeyi KSM 22 solved in PBS and added to DMEM medium to the final concentration of 0.5, 1, and 2 unit. Cells were exposed to glucanhydrolase solution or 0.1 % chlorhexidine and the cells cultured in DMEM with 10% FBS and 1% antibiotics as control. After exposure, the morphological change, cell attachment, and cell activity by MTT assay were evaluated in 0.5, 1.5, 3, 6, 24 hours after treatment. The cell proliferation and cell activity was also evaluated at 2 and 7 days after 1 minute exposure, twice a day. The cell morphology was similar between the Lipomyces smkeyi KSM 22 glucanhydrolase groups and control group during the incubation periods, while most fibroblasts remained as round cell regardless of incubation time in the chlorhexidine group. The numbers of the attached cells in the glucanhydrolase groups were comparable to that of control and significantly higher than the chlorhexidine group. The numbers of the proliferated cells in the glucanhydrolase groups at 7 days of incubation were comparable to the control group and higher than the chlorhexidine group. The cell activity in glucanhydrolase groups paralleled with the increased cell number by attachment and proliferation. According to these results, Lipomyces starkeyj KSM 22 glucanhydrolase has little harmful effect on attachment and proliferation of human gingival fibroblasts, in contrast to 0.1% chlorhexidine which was cytotoxic to human gingival fibroblasts. Therefore this glucanhydrolase preparation is considered as a safe and promising agent for new mouthwash formula in the near future.
Keywords
Lipomyces starkeyi KSM 22 glucanhydrolase; chlorhexidine; human gingival fibroblasts; cytotoxic;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Hull P. Chemical inhibition of plaque. J Clin Periodontol 7: 431-442, 1980   DOI
2 Labene R. A clinical study of the effect of dextranase on human dental plaque. J Am Dent Assoc 82: 132-135, 1971   DOI
3 Takada K, Shiota T, Curtiss R III, Michalek S. Inhibition of plaque and caries formation by a glucan produced by Streptococcus mutans mutants UAB108. Infect Immun 50: 833-843, 1985
4 Kim DM, Day DF. Isolation of a dextrnase constitutive mutans of Lipomyces starkeyi and its use for the production of clinical size dextran. Letters in Applied Microb 20: 268-270, 1995   DOI   ScienceOn
5 Ryu SJ, Kim DM, Ryu HJ, Chiba S, Kimura A, Day DF. Purification and partial characterization of a novel glucanhydrolase from Lipomyces starkeyi KSM 22 and its use for inhibition of insoluble glucan formation. Biosci Biotechnol Biochem 64: 223-228, 2000   DOI   ScienceOn
6 Ogata Y, Naomi N, Takeshi S, Furuyama S, Sugira H. Comparison of the characteristics of human gingival fibroblasts and periodontal ligament cells. J Periodontol 66: 1025-1031, 1995   DOI
7 Caldwell R, Sandham HJ, Mann W, Finn S, Formicola A. The effect of a dextranase mouth wash on dental plaque in young adults and children. J Am Dent Assoc 82: 124-131, 1971   DOI
8 Kim DM, Ryu SJ, Heo SJ, Kim DW, Kim HS. Characterization of a novel carbohydrase from Lipomyces starkeyi KSM 22 for dental application. J Microbiol Biotechnol 9: 260-264, 1999   과학기술학회마을
9 Segreto VA, Collins EM, Beiswanger BB, De la Rosa MR, Isaacs RL, Lang NP, Mallatt ME, Meckel AH. A Comparison of mouthwashes containing two concentrations of chlorhexidine. J Periodont Res 21(SuppI 16): 23-32, 1986   DOI
10 송우성, 손은주, 김도만, 정현주 Dextranase 함유구강세정액의 치태 제거 및 치은염 예방효과에 관한 임상적 연구. 대한치주과학회지 31: 371-388, 2001
11 손은주, 김영준, 김도만, 정현주. 실험적 치은염에서 dextranase 함유 구강 세정액의 양치 효과. 대한치주과학회지 31: 401-420, 2001   과학기술학회마을   ScienceOn
12 Kim DM, Day DF. A new process for the production of clinical dextran by mixed--culture fermentation of Lipomyces starkeyi KSM and Leuconostoc mesenteroides. Enzyme Microb Technol 16: 844-848, 1994   DOI   ScienceOn
13 류인철. 수종의 상용 세치제들의 항균 및 항염효과 비교 연구. 대한치주과학회지 26: 557-565, 1996
14 Block P, Dooley C, Howe E. The retardation of spontaneous periodontal disease and the prevention of caries in hamsters with dextranase. J Periodontol 40: 105-110, 1969   DOI
15 Johnson R, Rozanis J. A review of chemotherapeutic plaque control. Oral Surg Oral Moo Oral Pathol 47: 136-141, 1979   DOI
16 Banting D, Bosma M, Ballmer B. Clinical effectiveness of a 0.12% chlorhexidine mouth rinse over two years. J Dent Res 68: 1716-1718, 1989
17 Johnson I. Dextranase activity of streptococcal isolates from human dental plaques. Microbios 65: 264-265, 1991
18 Pucher J, Daniel J. The effect of chlorhexidine digluconate on human fibroblasts in vitro. J Periodontol 62: 526-532, 1993
19 Goldschmidt P, Cogen R, Taubman S. Cytopathologic effects of chlorhexidine on human cells. J Periodontol 48: 212-215, 1977   DOI
20 Igarashi T, Yarnmoto A, Goto N. Detection of dextranase-producing gram-negative oral bacteria. Oral Microbiol Immunol 13:382-386, 1998   DOI   ScienceOn
21 Sommennan MJ, Archer SY, Foster RA. A comprehensive study of human periodontal ligament cells and gingival fibroblast in vitro. J Dent Res 67: 66-70, 1988   DOI   ScienceOn
22 Wellington J, Shaw J, Walker G. Influence of growth rate on the relative activities of free and bound dextranase and dextranase inhibitor in continuous cultures of Streptococcus sobrinus. Microbios 79: 121-129, 1994
23 Mariotti AJ, Cochran DL. Characterization of fibroblasts derived from human periodontal ligament and gingiva. J Periodontol 61:103-111, 1990   DOI
24 Lobene R. Clinical status of plaque control agents: An overview. J Dent Res 58: 2381-2388, 1979   DOI   PUBMED   ScienceOn
25 Mariotti AJ, Rumpf DA, Chlorhexidine-induced changes to human gingival fibroblast collagen and non-collagen protein production. J Periodontol 70: 1443-1448, I999   DOI   ScienceOn
26 Igarashi T, Yammoto A, Goto N. Characterization of the Dextranase gene(dex) of Streptococcus mutans and its recombinant product in an Escherichia coli host. Microbiol Immunol 39: 387-391, 1995   DOI
27 Walker G. Metabolism of the polysaccharides of human dental plaque: Release of Dextranase in batch cultures of Streptococcus mutans. J Gegeneral Microbiol 27: 201-208, 1981